H. Chardón

883 total citations
42 papers, 413 citations indexed

About

H. Chardón is a scholar working on Molecular Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, H. Chardón has authored 42 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 14 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in H. Chardón's work include Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Pneumonia and Respiratory Infections (10 papers). H. Chardón is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Pneumonia and Respiratory Infections (10 papers). H. Chardón collaborates with scholars based in France, Réunion and Lebanon. H. Chardón's co-authors include Frédéric Laurent, François Vandenesch, Marisa Haenni, Jean-Yves Madec, Michèle Bes, M.E. Reverdy, Anne Tristan, H. Drugeon, Françis Mégraud and J. Sirot and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.

In The Last Decade

H. Chardón

41 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Chardón France 10 165 129 107 104 92 42 413
H. Talsania United Kingdom 11 200 1.2× 89 0.7× 142 1.3× 95 0.9× 153 1.7× 15 435
E Molitoris United States 14 157 1.0× 136 1.1× 92 0.9× 105 1.0× 191 2.1× 26 512
G. Brick United Kingdom 8 249 1.5× 154 1.2× 75 0.7× 130 1.3× 141 1.5× 9 469
M.I. Morosini Spain 9 92 0.6× 205 1.6× 81 0.8× 129 1.2× 51 0.6× 13 393
Rikke Lykke Poulsen Denmark 7 196 1.2× 100 0.8× 76 0.7× 42 0.4× 103 1.1× 8 355
M S Barrett United States 11 238 1.4× 107 0.8× 100 0.9× 121 1.2× 125 1.4× 18 416
Carol Webster United Kingdom 14 187 1.1× 285 2.2× 144 1.3× 131 1.3× 164 1.8× 17 615
Sara Kaufman Argentina 13 195 1.2× 128 1.0× 75 0.7× 180 1.7× 58 0.6× 39 483
Harold G. Jensen United States 12 158 1.0× 56 0.4× 135 1.3× 55 0.5× 100 1.1× 25 718
Michel Auzou France 14 204 1.2× 142 1.1× 109 1.0× 117 1.1× 149 1.6× 24 422

Countries citing papers authored by H. Chardón

Since Specialization
Citations

This map shows the geographic impact of H. Chardón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Chardón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Chardón more than expected).

Fields of papers citing papers by H. Chardón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Chardón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Chardón. The network helps show where H. Chardón may publish in the future.

Co-authorship network of co-authors of H. Chardón

This figure shows the co-authorship network connecting the top 25 collaborators of H. Chardón. A scholar is included among the top collaborators of H. Chardón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Chardón. H. Chardón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sifré, Elodie, Astrid Ducournau, Pauline Floch, et al.. (2015). EUCAST recommendations for antimicrobial susceptibility testing applied to the three main Campylobacter species isolated in humans. Journal of Microbiological Methods. 119. 206–213. 44 indexed citations
2.
Bérenger, Jean-Michel, et al.. (2013). A New Challenge for Hospitals in Southeast France: Monitoring Local Populations ofAedes albopictusto Prevent Nosocomial Transmission of Dengue or Chikungunya. Journal of the American Mosquito Control Association. 29(1). 81–83. 7 indexed citations
3.
Laurent, Frédéric, H. Chardón, Marisa Haenni, et al.. (2012). MRSA HarboringmecA Variant GenemecC, France. Emerging infectious diseases. 18(9). 1465–1467. 70 indexed citations
4.
Blanc, Véronique, et al.. (2012). Épidémiologie des bêtalactamases à spectre étendu (BLSE) chez les entérobactéries dans un hôpital du sud de la France, 1999–2007. Pathologie Biologie. 61(2). 38–43. 14 indexed citations
5.
Chardón, H., et al.. (2009). Resistance to macrolides by ribosomal mutation in clinical isolates of Turicella otitidis. International Journal of Antimicrobial Agents. 34(3). 274–277. 6 indexed citations
6.
Soussy, Claude–James, F. W. Goldstein, H. Dabernat, et al.. (2003). In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Clinical Microbiology and Infection. 9(10). 997–1005. 18 indexed citations
7.
Sirot, J., Marie-Hélène Nicolas-Chanoine, H. Chardón, et al.. (2002). Susceptibility of Enterobacteriaceae to β-lactam agents and fluoroquinolones: a 3-year survey in France. Clinical Microbiology and Infection. 8(4). 207–213. 25 indexed citations
9.
Roussel‐Delvallez, M., H. Chardón, T. Fosse, et al.. (2002). Change of pneumococcal resistance to antibiotics in adults between 1995 and 1997: a study in eight French counties. International Journal of Antimicrobial Agents. 19(5). 389–396. 5 indexed citations
10.
Jehl, F., Jean‐Pierre Bédos, R Poirier, et al.. (2002). Enquête nationale sur les pneumonies communautaires à pneumocoque chez des malades adultes hospitalisés. Médecine et Maladies Infectieuses. 32(6). 267–283. 6 indexed citations
11.
Nicolas-Chanoine, Marie-Hélène, Patrice Nordmann, A. Philippon, et al.. (2001). Multicenter Evaluation of an Automated System Using Selected Bacteria That Harbor Challenging and Clinically Relevant Mechanisms of Resistance to Antibiotics. European Journal of Clinical Microbiology & Infectious Diseases. 20(9). 626–635. 9 indexed citations
12.
Pina, P., et al.. (2000). [Antibiotic sensitivity of enterobacteria in intensive care units].. PubMed. 48(5). 485–9. 2 indexed citations
13.
Chardón, H., T. Fosse, G. Laurans, et al.. (1999). A 1-year study of antibiotic resistance among paediatric pneumococcal isolates in 1995 from four regions of France. International Journal of Antimicrobial Agents. 13(2). 109–115. 5 indexed citations
14.
Collet, L., H. Chardón, Vincent Jarlier, et al.. (1994). Etude de la sensibilité à l'Augmentin® de 998 souches de Escherichia coli isolées en 1992 dans quatre centres hospitaliers français (Etude COLICERIB I). Médecine et Maladies Infectieuses. 24(6-7). 765–773. 16 indexed citations
15.
Bingen, Édouard, et al.. (1992). Killing kinetics of five orally administered antibiotics at clinically achievable concentrations againstmoraxella catarrhalis. European Journal of Clinical Microbiology & Infectious Diseases. 11(10). 923–926. 2 indexed citations
16.
Jp, Routy, et al.. (1990). [HIV-1 primo-infection and cytomegalovirus reactivation in 2 intravenous drug users. Prognostic significance].. PubMed. 141(2). 194–5. 1 indexed citations
17.
Chardón, H., et al.. (1989). [In vitro comparative activity of five macrolides against 190 Branhamella catarrhalis strains].. PubMed. 37(5). 382–5. 2 indexed citations
18.
Raoult, Didier, et al.. (1985). Actinomyces odontolyticus infections: review of six patients. Journal of Infection. 11(2). 125–129. 14 indexed citations
19.
Chardón, H., et al.. (1983). Description d'une nouvelle observation de septicémie à Pasteurella multocida. Médecine et Maladies Infectieuses. 13(9). 520–522. 2 indexed citations
20.
Kazmierczak, A, et al.. (1973). [Enzymatic constants (Km and Vmax) of beta-lactamases, measured by a computerized micro-acidimetric method].. PubMed. 124(3). 259–68. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026